ANI Expects Growth From Launches And Novitium Integration

As Company Expects Cortrophin Gel To Have Commercial Longevity

Launch
ANI Pharma expects the company to grow on the back of lead assets like Cortrophin Gel • Source: Alamy

More from Earnings

More from Business